Maze Therapeutics (MAZE) Other Non Operating Income (2024 - 2026)

Maze Therapeutics has reported Other Non Operating Income for 3 years, with the latest figure at $2.3 million in Q1 2026.

• Quarterly Other Non Operating Income fell 10.33% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 266.32% YoY) and the FY2025 annual result came in at $85000.0, up 100.96% from the prior year.
• Other Non Operating Income improved to $2.3 million in Q1 2026 per MAZE's latest filing, from $85000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $2.6 million in Q1 2025 and troughed at -$4.8 million in Q1 2024.
• A 3-year average of -$541714.3 and a median of $85000.0 in 2025 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2025 and 2026: Other Non Operating Income soared 154.93% in 2025, then decreased 10.33% in 2026.
• Over 3 years, Other Non Operating Income stood at -$1.6 million in 2024, then jumped by 105.17% to $85000.0 in 2025, then soared by 2658.82% to $2.3 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $2.3 million, $85000.0, and $2.6 million for Q1 2026, Q4 2025, and Q1 2025 respectively.